Brief: Medigene Raises 2020 EBITDA Target

Medigene AG

27/05/2020 17:30

May 27 (Reuters) - MEDIGENE AG  MDG1k.DE :
    * ADJUSTS 2020 FINANCIAL GUIDANCE AND EXPECTS IMPROVED
EBITDA
RESULT
    * TODAY DECIDED TO ADJUST ITS PREVIOUS 2020 FULL-YEAR
GUIDANCE
WITH LOWER RESEARCH AND DEVELOPMENT EXPENSES
    * TOTAL REVENUE GUIDANCE REMAINS UNCHANGED AT EUR 7 - 9 M.
    * GUIDANCE FOR ANTICIPATED 2020 EBITDA LOSS IMPROVES TO
RANGE OF
EUR19 - 27 M (PREVIOUSLY EBITDA LOSS OF EUR24 - 32 M)
    * BASED ON THIS PLANNING, COMPANY IS FINANCED UNTIL END OF
2021

Source text for Eikon:  ID:nPexLngl8a 
Further company coverage:  MDG1k.DE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))